HIV PRE-EXPOSURE PROPHYLAXIS USE

Clinical trials for HIV PRE-EXPOSURE PROPHYLAXIS USE explained in plain language.

Never miss a new study

Get alerted when new HIV PRE-EXPOSURE PROPHYLAXIS USE trials appear

Sign up with your email to follow new studies for HIV PRE-EXPOSURE PROPHYLAXIS USE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1

Choice of injection location could be key to stopping HIV

Prevention Not yet recruiting

This study aims to find the best way to deliver a highly effective, twice-yearly HIV prevention injection called lenacapavir. It will test if offering people a choice of where to get their follow-up injections—at home, in the community, or at a clinic—helps them stay on the medic…

Matched conditions: HIV PRE-EXPOSURE PROPHYLAXIS USE

Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Prevention

Last updated Mar 24, 2026 12:02 UTC

HIV PRE-EXPOSURE PROPHYLAXIS USE

Get alerted when new HIV PRE-EXPOSURE PROPHYLAXIS USE trials appear

Choice of injection location could be key to stopping HIV